[Febuxostat or allopurinol in patients with gout : Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Morbidities (CARES)]. 2020

R Alten, and M Mischkewitz, and S Nitschmann
Abteilung Innere Medizin II - Rheumatologie, Klinische Immunologie, Osteologie, Physikalische Therapie und Sportmedizin, Schlosspark-Klinik, Heubnerweg 2, 14059, Berlin, Deutschland. rieke.alten@schlosspark-klinik.de.

UI MeSH Term Description Entries
D009017 Morbidity The proportion of patients with a particular disease during a given year per given unit of population. Morbidities
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D006073 Gout Metabolic disorder characterized by recurrent acute arthritis, hyperuricemia and deposition of sodium urate in and around the joints, sometimes with formation of URIC ACID calculi. Gouts
D006074 Gout Suppressants Agents that increase uric acid excretion by the kidney (URICOSURIC AGENTS), decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout. Antigout Agents,Antihyperuricemic,Antihyperuricemics,Agents, Antigout,Suppressants, Gout
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069465 Febuxostat A thiazole derivative and inhibitor of XANTHINE OXIDASE that is used for the treatment of HYPERURICEMIA in patients with chronic GOUT. 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid,TEI 6720,TEI-6720,Uloric,6720, TEI,TEI6720
D000493 Allopurinol A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms. Allohexal,Allohexan,Alloprin,Allopurin,Allorin,Allpargin,Allural,Apulonga,Apurin,Atisuril,Bleminol,Caplenal,Capurate,Cellidrin,Embarin,Foligan,Hamarin,Jenapurinol,Lopurin,Lysuron,Milurit,Milurite,Novopurol,Pan Quimica,Progout,Pureduct,Purinol,Remid,Rimapurinol,Roucol,Suspendol,Tipuric,Uribenz,Uridocid,Uripurinol,Urosin,Urtias,Xanthomax,Xanturic,Zygout,Zyloprim,Zyloric

Related Publications

R Alten, and M Mischkewitz, and S Nitschmann
March 2018, The New England journal of medicine,
R Alten, and M Mischkewitz, and S Nitschmann
July 2012, American heart journal,
R Alten, and M Mischkewitz, and S Nitschmann
January 2022, Frontiers in pharmacology,
R Alten, and M Mischkewitz, and S Nitschmann
October 2022, Seminars in arthritis and rheumatism,
R Alten, and M Mischkewitz, and S Nitschmann
June 2018, Drug and therapeutics bulletin,
R Alten, and M Mischkewitz, and S Nitschmann
February 2012, BMC musculoskeletal disorders,
Copied contents to your clipboard!